glucagon has been researched along with spironolactone in 4 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (spironolactone) | Trials (spironolactone) | Recent Studies (post-2010) (spironolactone) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 7,222 | 960 | 1,923 |
| Protein | Taxonomy | glucagon (IC50) | spironolactone (IC50) |
|---|---|---|---|
| Chain A, Mineralocorticoid receptor | Homo sapiens (human) | 0.049 | |
| Chain A, Mineralocorticoid receptor | Homo sapiens (human) | 0.049 | |
| Estrogen receptor | Homo sapiens (human) | 5.702 | |
| Glucocorticoid receptor | Homo sapiens (human) | 4.0745 | |
| Progesterone receptor | Homo sapiens (human) | 1.675 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.9025 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0315 | |
| Androgen receptor | Homo sapiens (human) | 0.3585 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.406 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.9025 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.9025 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.9025 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 6.92 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arky, RA; Boulter, PR; O'Brian, JT; Saudek, CD; Spark, RF | 1 |
| Bartels, O; Junge, O; Topf, G | 1 |
| Lvoff, R; Wilcken, DE | 1 |
| Ramdohr, B | 1 |
1 review(s) available for glucagon and spironolactone
| Article | Year |
|---|---|
Renin, aldosterone and glucagon in the natriuresis of fasting.
Topics: Adrenocorticotropic Hormone; Aldosterone; Dietary Carbohydrates; Dietary Proteins; Fasting; Fludrocortisone; Glucagon; Humans; Kidney Tubules, Distal; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Natriuresis; Obesity; Potassium; Renin; Secretory Rate; Sodium; Spironolactone | 1975 |
3 other study(ies) available for glucagon and spironolactone
| Article | Year |
|---|---|
[Drug therapy of shock].
Topics: Bicarbonates; Dehydration; Dihydroergotoxine; Furosemide; Glucagon; Humans; Methylprednisolone; Peritoneal Dialysis; Plasma Substitutes; Shock; Shock, Cardiogenic; Shock, Septic; Spironolactone; Sympathomimetics; Theophylline | 1978 |
Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Digitalis Glycosides; Female; Furosemide; Glucagon; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Nausea; Postoperative Complications; Prochlorperazine; Shock, Cardiogenic; Spironolactone | 1972 |
Drug therapy in cardiogenic shock.
Topics: Cardiac Output; Digitalis Glycosides; Dopamine; Glucagon; Hemodynamics; Humans; Isoproterenol; Metaproterenol; Myocardial Infarction; Norepinephrine; Phentolamine; Plasma Substitutes; Shock, Cardiogenic; Spironolactone | 1973 |